NK cells are never alone: crosstalk and communication in tumour microenvironments

Y Zhou, L Cheng, L Liu, X Li - Molecular Cancer, 2023 - Springer
Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour
microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) …

Decellularized ECM hydrogels: prior use considerations, applications, and opportunities in tissue engineering and biofabrication

J Kort-Mascort, S Flores-Torres, O Peza-Chavez… - Biomaterials …, 2023 - pubs.rsc.org
Tissue development, wound healing, pathogenesis, regeneration, and homeostasis rely
upon coordinated and dynamic spatial and temporal remodeling of extracellular matrix …

In vitro immunity: an overview of immunocompetent organ-on-chip models

AI Morrison, MJ Sjoerds, LA Vonk, S Gibbs… - Frontiers in …, 2024 - frontiersin.org
Impressive advances have been made to replicate human physiology in vitro over the last
few years due to the growth of the organ-on-chip (OoC) field in both industrial and academic …

Vascularized lung cancer model for evaluating the promoted transport of anticancer drugs and immune cells in an engineered tumor microenvironment

D Kim, KS Hwang, EU Seo, S Seo… - Advanced …, 2022 - Wiley Online Library
The tumor microenvironment (TME) is the environment around the tumor, including blood
vessels, immune cells, fibroblasts, signaling molecules, and the extracellular matrix (ECM) …

Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment

K Ravi, TJM Manoharan, KC Wang, B Pockaj… - Biomaterials, 2024 - Elsevier
Cancer thrives in a complex environment where interactions between cellular and acellular
components, surrounding the tumor, play a crucial role in disease development and …

Exploring tumor–immune interactions in co-culture models of T cells and tumor organoids derived from patients

SR Jeong, M Kang - International Journal of Molecular Sciences, 2023 - mdpi.com
The use of patient-derived tumor tissues and cells has led to significant advances in
personalized cancer therapy and precision medicine. The advent of genomic sequencing …

[HTML][HTML] Next generation organoid engineering to replace animals in cancer drug testing

S Hockney, J Parker, JE Turner, X Todd… - Biochemical …, 2023 - Elsevier
Cancer therapies have several clinical challenges associated with them, namely treatment
toxicity, treatment resistance and relapse. Due to factors ranging from patient profiles to the …

Progress in develo** microphysiological systems for biological product assessment

M Mansouri, J Lam, KE Sung - Lab on a Chip, 2024 - pubs.rsc.org
Microphysiological systems (MPS), also known as miniaturized physiological environments,
have been engineered to create and study functional tissue units capable of replicating …

A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model

M Marzagalli, G Pelizzoni, A Fedi, C Vitale… - … in bioengineering and …, 2022 - frontiersin.org
The success of immunotherapeutic approaches strictly depends on the immune cells
interaction with cancer cells. While conventional in vitro cell cultures under-represent the …

Evaluation of cancer immunotherapy using mini-tumor chips

Z Ao, H Cai, Z Wu, L Hu, X Li, C Kaurich, M Gu… - …, 2022 - pmc.ncbi.nlm.nih.gov
Rationale: Predicting tumor responses to adjuvant therapies can potentially help guide
treatment decisions and improve patient survival. Currently, tumor pathology, histology, and …